Area of research
Molecular Biology · Oncology
Research interest
Research interests include Biology, Mitochondrion, Cell biology, Cancer research, DNA damage, and Cytosol.
Inducing Targeted, Caspase-Independent Apoptosis with New Chimeric Proteins for Treatment of Solid Cancers
Rescue of the First Mitochondrial Membrane Carrier, the mPiC, by TAT-Mediated Protein Replacement Treatment
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response
The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response
The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver–Serum–Brain Response
Systematic Approaches to Study Eclipsed Targeting of Proteins Uncover a New Family of Mitochondrial Proteins
DPYSL2 interacts with JAK1 to mediate breast cancer cell migration
Depletion of Fumarate Hydratase, an Essential TCA Cycle Enzyme, Drives Proliferation in a Two-Step Model
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment
TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human Diseases
Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimer’s Disease Mice
Clonally stable Vκ allelic choice instructs Igκ repertoire
Tissue-specific DNA demethylation is required for proper B-cell differentiation and function
Heterologous mitochondrial targeting sequences can deliver functional proteins into mitochondria
Replacement of the C6ORF66 Assembly Factor (NDUFAF4) Restores Complex I Activity in Patient Cells